BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20062082)

  • 1. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.
    Baert JL; Monte D; Verreman K; Degerny C; Coutte L; de Launoit Y
    Oncogene; 2010 Mar; 29(12):1810-20. PubMed ID: 20062082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
    Bojović BB; Hassell JA
    DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
    Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
    Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells.
    Yi C; Li S; Chen X; Wiemer EA; Wang J; Wei N; Deng XW
    Cancer Res; 2005 Jul; 65(13):5835-40. PubMed ID: 15994960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
    Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
    Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
    Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
    Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
    Li DQ; Ohshiro K; Reddy SD; Pakala SB; Lee MH; Zhang Y; Rayala SK; Kumar R
    Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17493-8. PubMed ID: 19805145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
    Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
    J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription.
    Firlej V; Ladam F; Brysbaert G; Dumont P; Fuks F; de Launoit Y; Benecke A; Chotteau-Lelievre A
    J Cell Sci; 2008 Oct; 121(Pt 20):3393-402. PubMed ID: 18827017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members.
    Verger A; Baert JL; Verreman K; Dewitte F; Ferreira E; Lens Z; de Launoit Y; Villeret V; Monté D
    Nucleic Acids Res; 2013 May; 41(9):4847-59. PubMed ID: 23531547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
    Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
    Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain.
    Baert JL; Beaudoin C; Coutte L; de Launoit Y
    J Biol Chem; 2002 Jan; 277(2):1002-12. PubMed ID: 11682477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
    Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
    Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner.
    Degerny C; de Launoit Y; Baert JL
    Biochim Biophys Acta; 2008 Mar; 1779(3):183-94. PubMed ID: 18243147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.
    Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH
    Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
    Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
    J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.